Business Update

Biothera beta glucans receive U.S. FDA GRAS designation

Published in Biotech Business Week, January 29th, 2007

Biothera announced that its dietary supplement and functional food ingredients are the first yeast beta glucans to be Generally Recognized As Safe (GRAS) under the provisions of U.S. Food and Drug Administration 21CFR170.35.

An independent panel of medical and toxicology experts recently determined that Biothera's WGP 3-6 and BetaRight 3-6 meet the requirements for self-affirmed GRAS status. The panel reviewed extensive scientific data, including safety, toxicology and manufacturing process data. Biothera will provide the U.S. FDA with notification of the GRAS Panel's decision.

"Achieving GRAS status for our ingredients is an important milestone in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2007-01-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry